Results 51 to 60 of about 3,630,045 (162)

Educational technology for fatigue management related to antineoplastic chemotherapy

open access: yes, 2019
Objective: To construct and validate an educational technology (ET) on fatigue and non-pharmacological strategies for the management of this symptom in people with cancer undergoing outpatient antineoplastic chemotherapy.
Marcela Maria de Melo Perdigão (7528202)   +5 more
core   +1 more source

Risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting

open access: yes, 2020
OBJETIVO: Estimar a incidência e avaliar os fatores de risco para náuseas e vômitos induzidos por antineoplásicos com alto e moderado potencial emético em pacientes adultos, no primeiro ciclo de tratamento.
Simino, Giovana Paula Rezende   +17 more
core   +1 more source

Chemical characterization and antineoplastic effect of oligosaccharides from Cabernet Franc red wine in mammary tumor model in mice

open access: yes, 2022
The present study characterized oligosaccharide compounds (Oligo) in Cabernet Franc red wine and investigated its antineoplastic effects against mammary tumor cells in vivo and in vitro, isolated or in combination with chemotherapy.
Klassen, Giseli   +25 more
core   +1 more source

Biochemical aspects of the combined use of taxanes, irradiation and other antineoplastic agents for the treatment of anaplastic thyroid carcinoma

open access: yes, 2018
The review summarizes the results of the cycle of own research and literature data on biochemical mechanisms of combined action of taxanes with γ-irradiation and other antineoplastic agents on one of the most aggressive types of human cancer – anaplastic
O. I. Kovzun   +4 more
core   +1 more source

Acute Cytogenetic Effects of Antineoplastic Drugs on Peripheral Blood Lymphocytes in Cancer Patients Chromosome Aberrations and Micronuclei

open access: yes, 2002
Aims and Background The aim of the present study was to evaluate the individual sensitivity of cancer patients to different antineoplastic drugs administered in standard protocols by assessing their acute cytogenetic effects on peripheral blood ...
Nevenka Kopjar   +2 more
core   +1 more source

Diferenças no tratamento sistêmico do câncer no Brasil: meu SUS é diferente do teu SUS

open access: yesBrazilian Journal of Oncology, 2017
Objetivo: Identificar diferenças no tratamento sistêmico dos quatro tipos mais incidentes de câncer tratados no SUS e comparar os tratamentos oferecidos com as Diretrizes Terapêuticas (DTs) estabelecidas pelo Ministério da Saúde (MS), assim ...
Rafael Aliosha Kaliks   +3 more
doaj   +1 more source

Chemotherapy protocols used, according to histological type.

open access: yes, 2019
Chemotherapy protocols used, according to histological type.
Eduardo Weltman (5351846)   +8 more
core   +1 more source

Errors involving patients receiving intrathecal chemotherapy

open access: yes, 2010
Errors involving patients receiving intrathecal chemotherapy are a significant problem in oncology. Despite the improvement in the management of antineoplastic agents, unintentional intrathecal administration of chemotherapic drugs that are indicated ...
Scalzone, Maria   +6 more
core   +1 more source

Comparación del Hyper-CVAD con un régimen institucional en el tratamiento de la leucemia linfoblástica aguda del adulto en un hospital de México

open access: yesRevista Peruana de Medicina Experimental y Salud Pública
Con el objetivo de evaluar la mortalidad y toxicidad del protocolo Hyper-CVAD utilizado como primera línea de tratamiento de la leucemia linfoblástica aguda se realizó un estudio de cohorte retrospectiva en pacientes de 40 años a menos durante marzo a ...
Christian Omar Ramos-Peñafiel   +12 more
doaj  

Comparative survival outcomes of surgical resection versus radiotherapy after FOLFIRINOX in borderline resectable and locally advanced pancreatic cancer [PDF]

open access: yesPrecision and Future Medicine
Purpose This study evaluated the clinical outcomes and prognostic factors in patients with borderline resectable pancreatic cancer (BRPC) and locally advanced pancreatic cancer (LAPC) treated with upfront FOLFIRINOX followed by local-regional therapy ...
Jiwon Yu   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy